序号 |
标题 |
次数 |
作者 |
发布时间 |
82936 |
(DNAZTzDMP)2Ni(H2O)2][NO3]2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
111 |
WYQ |
2024-12-03 |
82937 |
AB1-HLys-DOTA,DOTA偶联阳离子肽 |
105 |
wyh |
2024-12-03 |
82938 |
PAMAM-PEG-CKAAKN 树枝状大分子聚酰胺胺-聚乙二醇-CKAAKN多肽 |
108 |
zyl |
2024-12-03 |
82939 |
(NH2TzDMP)3Ni][NO3]2;3-氨基-6-(3,5-二甲基吡唑)四嗪配合物 |
89 |
WYQ |
2024-12-03 |
82940 |
(DNAZTzDMP)2Co(H2O)2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
129 |
WYQ |
2024-12-03 |
82941 |
DOTA-1-nal 3-奥曲肽,Ga-DOTA-1-Nal3-octreotide |
80 |
wyh |
2024-12-03 |
82942 |
PAMAM-PEG-SP94 树枝状大分子聚酰胺胺-聚乙二醇-SP94多肽 |
109 |
zyl |
2024-12-03 |
82943 |
[(DNAZTzDMP)2Co(H2O)2](3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物) |
137 |
WYQ |
2024-12-03 |
82944 |
LLP2A-DOTA-PEG(2000), LLP2A-DOTA-聚乙二醇(2000) |
96 |
wyh |
2024-12-03 |
82945 |
[(NH2TzDMP)2Co(H2O)(NO3)][NO3](3-氨基-6-(3,5-二甲基吡唑)四嗪配合物) |
107 |
WYQ |
2024-12-03 |
82946 |
3-(3,3'-dinitroazetidine)-6-(3,5-dimethylpyrazole)tetrazine(DNAZTzDMP) |
109 |
WYQ |
2024-12-03 |
82947 |
PAMAM-PEG-PTP 树枝状大分子聚酰胺胺-聚乙二醇-PTP多肽 |
101 |
zyl |
2024-12-03 |
82948 |
DOTA-SSTR;DOTA修饰生长抑素受体SSTR |
156 |
wyh |
2024-12-03 |
82949 |
NOTA-PEG(7)-Tz;大环化合物-七聚乙二醇-四嗪;NOTA-PEG(7)-Tetrazine |
118 |
WYQ |
2024-12-03 |
82950 |
PAMAM-PEG-RGDS 树枝状大分子聚酰胺胺-聚乙二醇-RGDS多肽 |
104 |
zyl |
2024-12-03 |
82951 |
PEGylated tetrazine;PEG4-Tz;聚乙二醇化四嗪;PEGylated Tz |
147 |
WYQ |
2024-12-03 |
82952 |
DOTA-ZOL, DOTA-唑来膦酸 |
95 |
wyh |
2024-12-03 |
82953 |
NHS-s-s-tetrazine;N-羟基琥珀酰亚胺-双硫键-四嗪;NHS-s-s-Tz |
126 |
WYQ |
2024-12-03 |
82954 |
PAMAM-PEG-c(RGDfC) ,树枝状大分子聚酰胺胺-聚乙二醇-c(RGDfC)多肽 |
155 |
zyl |
2024-12-03 |
82955 |
3-amino-6-(3,5-dimethylpyrazole)tetrazine(NH2TzDMP、3-氨基-6-(3,5-二甲基吡唑)四嗪) |
83 |
WYQ |
2024-12-03 |
82956 |
DOTA-cyclo(RGDyK) 生物医药探针 |
93 |
zcy |
2024-12-03 |
82957 |
Gd-DOTA-氮氧化合物,Gd-DOTA-NOx |
95 |
wyh |
2024-12-03 |
82958 |
PAMAM-PEG-Angiopep-2,树枝状大分子聚酰胺胺-聚乙二醇-Angiope-2多肽 |
107 |
zyl |
2024-12-03 |
82959 |
cas:250612-06-7 DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 DOTA-RGD探针二聚体 |
89 |
zcy |
2024-12-03 |
82960 |
MF-AspDOTA树脂 ,环烯配体AspDOTA功能化三聚氰胺-甲醛(MF)树脂 |
110 |
wyh |
2024-12-03 |
82961 |
DOTA-Octreotide 大环配体-奥曲肽 |
102 |
zcy |
2024-12-03 |
82962 |
[18F]F-Tz-PEG11-NODA;[18F]F-四嗪-聚(乙二醇)11-1,4,7-三氮杂环壬烷-1,4-二乙酸 |
133 |
WYQ |
2024-12-03 |
82963 |
PAMAMG5-SS-PEG2k 聚酰胺胺-双硫键-聚乙二醇 |
178 |
zyl |
2024-12-03 |
82964 |
5-BOTP-NOTA,5-BOTP偶联NOTA双功能螯合剂 |
149 |
wyh |
2024-12-03 |
82965 |
NOTA-Bn-NCS,147597-66-8 |
86 |
zcy |
2024-12-03 |
82966 |
(64)Cu-Tz-SarAr(64铜-四嗪-SarAr、(64)Cu-Tetrazine-SarAr) |
206 |
WYQ |
2024-12-03 |
82967 |
TA IN-CTLaunp,DOTA偶联乳糖修饰的壳聚糖聚合物(CTLChitlac) |
117 |
wyh |
2024-12-03 |
82968 |
CY5.5-PAMAM(G6)PEG2000-MAL 荧光CY5.5-聚酰胺胺(G6)-聚乙二醇-马来酰亚胺 |
108 |
zyl |
2024-12-03 |
82969 |
CB-TE2A;313229-90-2 |
117 |
zcy |
2024-12-03 |
82970 |
[99mTc]HYNIC-PEG11-Tz;[99mTc]联肼尼克酰胺-十一聚乙二醇-四嗪;[99mTc]HYNIC-PEG11-Tetrazine |
87 |
WYQ |
2024-12-03 |
82971 |
DOTA缀合的GF-17,DOTA-GF-17 |
255 |
wyh |
2024-12-03 |
82972 |
DOTA-Tetrazine(又称DOTA-TZ) |
102 |
WYQ |
2024-12-03 |
82973 |
PNIPAMAM-PEG-phosphoricacid,树枝状聚(N-异丙基丙烯酰胺)-聚乙二醇-磷酸 |
112 |
zyl |
2024-12-03 |
82974 |
Ga-DOTA标记的生长抑素类似物,Ga-DOTA-SSA |
144 |
wyh |
2024-12-03 |
82975 |
PNIPAMAM-PEG-Isothiocyanate树枝状聚(N-异丙基丙烯酰胺)-聚乙二醇-异硫氰酸盐 |
123 |
zyl |
2024-12-03 |
82976 |
Maleimido-mono-amide-DTPA(马来酰亚胺单酰胺-DTPA);2032239-75-9 |
106 |
zcy |
2024-12-03 |
82977 |
介孔二氧化硅包覆的金纳米棒,AuNRs@mSiO |
104 |
wyh |
2024-12-03 |
82978 |
DOTA-PEG11-Tz;DOTA-十一聚乙二醇-四嗪;DOTA-PEG11-Tetrazine |
107 |
WYQ |
2024-12-03 |
82979 |
PNIPAMAM-PEG-DOTA树枝状聚(N-异丙基丙烯酰胺)-聚乙二醇-四氮杂环十二烷四乙酸 |
112 |
zyl |
2024-12-03 |
82980 |
p-NH2-Bn-CHX-A”-DTPA;1105741-38-5 |
89 |
zcy |
2024-12-03 |